Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06841575 · ClinicalTrials.gov registry record · NA
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
A NA study, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06841575: Recruiting NA study, sponsored by Duke University.
NCT06841575 is a NA study that is actively recruiting participants, run by Duke University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06841575, a NA study, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adult volunteers, and adult and pediatric patients in clinic.
Primary Outcome
Measured by optical coherence tomography (OCT) reading.
Interventions
- DEVICE Auto-aligned OCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-03-23 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT06841575 shows while recruiting
NCT06841575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Auto-aligned OCT is the first listed.
NCT06841575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06841575 about?
NCT06841575 is a clinical study titled "Advancing Pediatric Retinal Imaging With Auto-aligned OCT". The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adult volunteers, and adult and pediatric patients in clinic.
What is the current status of trial NCT06841575?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-23. Estimated completion is 2027-09.
What interventions are being tested in trial NCT06841575?
The interventions under investigation include: Auto-aligned OCT (DEVICE).
Who is sponsoring clinical trial NCT06841575?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06841575's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI